Aardvark Therapeutics, Inc. Investor Lawsuit: Learn More Now Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Aardvark Therapeutics, Inc. (“Aardvark” or the “Company”) (NASDAQ: AARD) on behalf of investors that purchased or otherwise acquired Aardvark common stock pursuant and/or traceable to the Company’s initial public offering on or about February 13, 2025, or between February 13, 2025 and May 14, 2026 (the “Class Period”)…. Read MoreJoin Investigation
